Published in Gene Therapy Weekly, July 9th, 2009
"This technique requires the availability of prostate cells that meet several stringent requirements. Therefore, the main objective was to obtain prostate cell clones that undergo cell death with minimal survival of spontaneously resistant cells and that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.